(Q36779472)

16 August 2017

Effectiveness of nationwide screening program for neuroblastoma in Japan (English)

1 reference

16 August 2017

1 reference

Akinori Hisashige

1

1 reference

PMC publication ID

4825238

16 August 2017

NBS Evaluation Group

series ordinal

2

1 reference

16 August 2017

10 April 2014

1 reference

Global Journal of Health Science

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

4

1 reference

16 August 2017

94-106

1 reference

The epidemiology of neuroblastoma: a review

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Screening of infants and mortality due to neuroblastoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Response bias by neuroblastoma screening participation status and social desirability bias in an anonymous postal survey, Ishikawa, Japan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Neuroblastoma mass screening: The arguments for and against

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

A proposed staging for children with neuroblastoma.Children's cancer study group A

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Mass screening of neuroblastoma in Sapporo City, Japan.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Health economic analysis of the neonatal screening program in Japan.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Mass screening for neuroblastoma and estimation of costs

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

A population-based study of neuroblastoma incidence, survival, and mortality in North America.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

History of healthcare technology assessment in Japan.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Is the mass screening for neuroblastoma ineffective?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Mass screening for neuroblastoma at 6 months of age: difficult to justify

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Mass screening for neuroblastoma by HPLC and by non-HPLC: a review.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Recent advances in neuroblastoma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Neuroblastoma Screening at One Year of Age

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825238

Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan

4 December 2018

1 reference

12 December 2020

Mass screening of neuroblastoma in infancy

1 reference

12 December 2020

Laboratory techniques and neuroblastoma screening

1 reference

12 December 2020

Screening for neuroblastoma

1 reference

12 December 2020

A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations

1 reference

12 December 2020

A population-based study of the usefulness of screening for neuroblastoma

1 reference

12 December 2020

Mass screening for neuroblastoma and mortality in birth cohorts

1 reference

12 December 2020

Spontaneous regression of localized neuroblastoma detected by mass screening

1 reference

12 December 2020

Neuroblastoma screening in the United States: results of the Texas Outreach Program for Neuroblastoma Screening

1 reference

12 December 2020

Report of the 1998 Consensus Conference on Neuroblastoma Screening

1 reference

12 December 2020

[Risk factors for neuroblastoma]

1 reference

12 December 2020

Identifiers

DOI

10.5539/GJHS.V6N4P94

1 reference

16 August 2017

1 reference

PMC publication ID

4825238

16 August 2017

PubMed publication ID

25001552

1 reference

PMC publication ID

4825238